To evaluate the anti‐tumor activity of NK cells, cells extracted from tumors of NP‐treated mice were stained with anti‐KIR2DL1 antibodies to identify the percentage of NK cells in the tumor (Fig EV4B). This evidence concerns the gene KIR2DL1 and neoplasm.